Latest Aarey Drugs & Pharmaceuticals stock price
Aarey Drugs & Pharmaceuticals P/E Ratio
AAREYDRUGS • P/E ratio trend, valuation band, and sector comparison — all formatted to support journal-based trading review.
Current P/E Ratio
52.65
High Valuation
Very High - High growth expectations or significantly overvalued
Current Valuation Metrics
P/E Ratio
52.65
Current Price
₹69.37
EPS (TTM)
₹1.42
Exchange
NSE
Valuation Signal
Signal
Overvalued
Sector Context
Sector Average
53.41
Sector Median
30.38
Sector Rank
#11 of 131
Sector Percentile
8.4%
Key P/E Ratio Insights for Aarey Drugs & Pharmaceuticals
- Stock appears overvalued with PE of 52.65, suggesting caution for new investments
View the AAREYDRUGS equity price for detailed stock performance.
Related Pages for Aarey Drugs & Pharmaceuticals
Additional stock information and data for AAREYDRUGS
Sector P/E Ratio Comparison
Comparing Aarey Drugs & Pharmaceuticals with other companies in Healthcare sector
Sector Average
53.41
Sector Median
30.38
Lowest P/E
1.5
Highest P/E
628.04
Companies
131
| Company | Symbol | P/E Ratio | Market Cap (₹ Cr) | Valuation |
|---|---|---|---|---|
| Welcure Drugs & Pharmace… | WELCURE | 1.5 | ₹51 | Low |
| Ind Swift Laboratories | INDSWFTLAB | 3.18 | ₹733 | Low |
| Murae Organisor | MURAE | 3.86 | ₹55 | Low |
| Fermenta Biotech | FERMENTA | 9.01 | ₹1,010 | Low |
| Zenith Drugs | ZENITHDRUG | 9.06 | ₹84 | Low |
| Galaxy Medicare | GML | 9.5 | ₹32 | Low |
| Balaxi Pharmaceuticals | BALAXI | 10.06 | ₹139 | Low |
| Natco Pharma | NATCOPHARM | 10.8 | ₹17,006 | Low |
| Vasundhara Rasayans | VRL | 11.3 | ₹51 | Low |
| Mohini Health & Hygiene | MHHL | 11.84 | ₹69 | Low |